The impact of the Women's Health Initiative on clinical practice

Journal of the Society for Gynecologic Investigation

Volumn 9, Issue 5, 2002, Pages 251-253

  Speroff, Leon ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; PLACEBO; STATIN;

ATHEROSCLEROSIS; BREAST CANCER; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG MONITORING; EDITORIAL; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE; SYMPTOMATOLOGY; VAGINA BLEEDING; VASODILATATION;

AGED; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; WOMEN'S HEALTH;

EID: 0037057150     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(02)00189-2     Document Type: Editorial

References (7)

1. Writing Group for the Women's Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
2. Enserink M. Despite safety concerns, U.K. hormone study to proceed. Science. 297:2002;492.
3. Bush T.L. The not so randomized clinical trial. Int J Fertil. 46:2001;56-59.
4. Mikkola T.S., Clarkson T.B. Estrogen replacement therapy Atherosclerosis, and vascular function . Cardiovasc Res. 53:2002;605-619.
5. Herrington D.M., Espeland M.A., Crouse J.R. 3rd, et al. Estrogen replacement and brachial artery flow-mediated vasodilatation in older women. Arterioscl Thromb Vasc Biol. 21:2001;1955-1961.
6. Hodis H.N., Mack W.J., Lobo R.A., et al. Estrogen in the prevention of atherosclerosis A randomized, double-blind, placebo-controlled trial . Ann Intern Med. 135:2001;939-953.
7. Grady D., Wenger N.K., Herrington D., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease The Heart and Estrogen/progestin Replacement Study . Ann Intern Med. 132:2000;689-696.